Gaudi Clinical is a health care firm that engages in regenerative medicine outsourcing and cell processing contract establishments.
Gaudi Clinical has raised $8.9M in total funding. The most recent round was Series A. The last funding was announced in February 2025.
Gaudi Clinical's investors include Mizuho Capital, MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC), Shizuoka Capital, JIC Venture Growth Investments, Samurai Incubate.
Gaudi Clinical is headquartered in Hongo, Japan.
Gaudi Clinical is a health care firm that engages in regenerative medicine outsourcing and cell processing contract establishments.
Gaudi Clinical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gaudi Clinical — Funding & Investors." VCBacked, February 7, 2025, https://www.vcbacked.co/company/gaudi-clinical. Accessed November 14, 2026.
VCBacked. (2025). Gaudi Clinical — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/gaudi-clinical
{{cite web |title=Gaudi Clinical — Funding & Investors |url=https://www.vcbacked.co/company/gaudi-clinical |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Gaudi Clinical? Request a listing update